Open AccessWatchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death
Author(s) -
A.P. Levin,
Omar Saeed,
Joshua Z. Willey,
Charles J. Levin,
J. Fried,
Snehal R. Patel,
Daniel B. Sims,
J. Nguyen,
Julia Shin,
Veli K. Topkara,
P.C. Colombo,
Daniel J. Goldstein,
Yoshifumi Naka,
Hiroo Takayama,
Nir Uriel,
Ulrich P. Jorde
Publication year - 2016
Publication title -
circulation heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 104
eISSN - 1941-3297
pISSN - 1941-3289
DOI - 10.1161/circheartfailure.115.002896
Subject(s) - medicine , hemolysis , antithrombotic , destination therapy , ventricular assist device , surgery , watchful waiting , thrombosis , cardiology , heart failure , prostate cancer , cancer
Management of hemolysis in the setting of suspected device thrombosis in continuous-flow left ventricular assist device patients varies widely, ranging from watchful waiting with intensified antithrombotic therapy to early surgical device exchange. The aim of this study was to compare the outcomes of hemolysis events treated with surgical interventions versus medical management alone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom